This triple recognition in 2025 highlights a growing global awareness of the need for more effective, better-tolerated iron supplementation.
Developed by biotics solutions company, Probi, the concept includes the clinically studied probiotic strain, Lactiplantibacillus plantarum 299v (LP299V).
When combined with iron, LP299V enhances iron absorption and reduces the gastrointestinal side effects often associated with conventional supplements.
Iron deficiency is one of the world's most pressing nutritional challenges, affecting more than 30% of women of reproductive age globally.
Rather than simply adding more iron, Probi's patented strain helps the body absorb it more effectively.
LP299V supports iron uptake in two key ways: by keeping iron in its absorbable form and by increasing the body's expression of iron-converting enzymes.
This leads to better absorption from food and supplements.
"Recognition across three continents in a single year speaks to the urgent, global nature of this issue and to the promise of science-backed, biotic innovations in addressing it," said Martina Pettersson, Global Marketing Director at Probi.
The latest accolade, the 2025 NutraIngredients-Asia Award for Innovation in Women's Health, was presented in Bangkok on 17 September, following earlier honours in Europe and North America.
"This innovation has a critical role to play in Asia where iron deficiency continues to impact millions of women," said Karen Ong, Head of Asia-Pacific at Probi.
"This reinforces how accessible and well-tolerated solutions can make a meaningful difference."
LP299V has been studied for more than three decades. Originally known for its digestive benefits, it is now gaining recognition for its unique ability to increase iron absorption and support better health outcomes for women globally.